Page last updated: 2024-08-21

quinazolines and Cervical Tuberculous Lymphadenitis

quinazolines has been researched along with Cervical Tuberculous Lymphadenitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Amorim, JC; Arévalo, JMC1

Other Studies

1 other study(ies) available for quinazolines and Cervical Tuberculous Lymphadenitis

ArticleYear
Virtual screening, optimization and molecular dynamics analyses highlighting a pyrrolo[1,2-a]quinazoline derivative as a potential inhibitor of DNA gyrase B of Mycobacterium tuberculosis.
    Scientific reports, 2022, 03-18, Volume: 12, Issue:1

    Topics: Antitubercular Agents; DNA Gyrase; Humans; Molecular Dynamics Simulation; Mycobacterium tuberculosis; Quinazolines; Topoisomerase II Inhibitors; Tuberculosis, Lymph Node

2022